Item 1. Financial Statements
Item
1. Financial Statements
Cemtrex,
Inc. and Subsidiaries
Condensed
Consolidated Balance Sheets
(Unaudited)
March 31,
September 30,
Assets
2026
2025
Current assets
Cash and cash equivalents
$ 6,567,030
$ 4,974,303
Restricted cash
1,343,088
1,372,738
Marketable securities
5,030,448
-
Trade receivables, net
13,325,559
13,133,424
Trade receivables, net - related party
548,554
405,493
Inventory, net
6,740,579
6,584,944
Contract assets, net
2,208,569
980,164
Prepaid expenses and other current assets
2,167,209
1,556,432
Total current assets
37,931,036
29,007,498
Property and equipment, net
16,540,949
9,651,996
Right-of-use operating lease assets
2,833,949
2,003,967
Right-of-use finance lease assets
66,518
-
Royalties receivable, net - related party
-
190,475
Digital assets
1,085,163
1,158,238
Intangible assets, net of amortization
2,981,750
-
Goodwill
7,686,141
3,708,347
Other
1,610,868
2,067,755
Total Assets
$ 70,736,374
$ 47,788,276
Liabilities & Stockholders’ Equity
Current liabilities
Accounts payable
$ 4,566,512
$ 4,492,859
Sales tax payable
50,887
76,008
Revolving line of credit
2,035,697
3,176,096
Current maturities of long-term liabilities
8,770,319
8,925,497
Operating lease liabilities - short-term
1,249,135
918,391
Finance lease liabilities - short-term
331,818
-
Deposits from customers
548,745
158,344
Accrued expenses
2,555,108
2,223,521
Accrued payable on inventory in transit
174,076
652,179
Contract liabilities
2,348,384
1,655,055
Deferred revenue
1,019,351
1,383,036
Accrued income taxes
574,433
162,173
Total current liabilities
24,224,465
23,823,159
Long-term liabilities
Long-term debt
8,756,025
4,586,779
Long-term operating lease liabilities
1,641,599
1,153,221
Other long-term liabilities
290,000
289,483
Deferred revenue - long-term
371,551
482,978
Warrant liabilities
743,499
8,735,197
Total long-term liabilities
11,802,674
15,247,658
Total liabilities
36,027,139
39,070,817
Commitments and contingencies
-
-
Stockholders’ equity
Preferred stock , $ 0.001 par value, 10,000,000 shares authorized, Series 1, 4,000,000 shares authorized, 2,840,919 shares issued and 2,776,819 shares outstanding as of March 31, 2026 and 2,705,327 shares issued and 2,641,227 shares outstanding as of September 30, 2025 (liquidation value of $ 10 per share)
2,841
2,705
Series C, 100,000 shares authorized, 50,000 shares issued and outstanding at March 31, 2026 and September 30, 2025
50
50
Preferred stock, value
50
50
Common stock, $ 0.001 par value, 70,000,000 shares authorized, 10,078,089 shares issued and outstanding at March 31, 2026 and 830,606 shares issued and outstanding at September 30, 2025
10,078
831
Additional paid-in capital
151,331,793
105,668,565
Accumulated deficit
( 119,046,840 )
( 99,397,741 )
Treasury stock, 64,100 shares of Series 1 Preferred Stock at March 31, 2026, and September 30, 2025
( 148,291 )
( 148,291 )
Accumulated other comprehensive income
2,559,604
2,591,340
Total stockholders’ equity
34,709,235
8,717,459
Total liabilities and stockholders’ equity
$ 70,736,374
$ 47,788,276
The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
Cemtrex,
Inc. and Subsidiaries
Condensed
Consolidated Statements of Operations
(Unaudited)
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
For the three months ended
For the six months ended
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
Revenues
$ 18,061,367
$ 27,250,269
$ 34,194,678
$ 40,990,168
Cost of revenues
11,214,163
15,084,814
21,725,608
23,122,777
Gross profit
6,847,204
12,165,455
12,469,070
17,867,391
Operating expenses
General and administrative
8,472,383
6,770,742
16,398,974
13,864,031
Research and development
546,858
777,889
1,048,293
1,667,972
Total operating expenses
9,019,241
7,548,631
17,447,267
15,532,003
Operating (loss)/income
( 2,172,037 )
4,616,824
( 4,978,197 )
2,335,388
Other income/(expense)
Other income/(expense), net
6,047
( 150,165 )
41,302
( 115,192 )
Interest expense
( 562,383 )
( 452,998 )
( 12,686,078 )
( 936,911 )
Changes in fair value of digital assets
( 628,581 )
-
( 1,098,441 )
-
Bargain purchase gain
2,068,047
-
2,068,047
-
Gain/(loss) on exercise of warrant liabilities
16,224
-
( 4,658,582 )
( 15,796,105 )
Changes in fair value of warrant liability
2,568,357
4,707,374
2,285,811
( 5,312,838 )
Total other income/(expense), net
3,467,711
4,104,211
( 14,047,941 )
( 22,161,046 )
Net income/(loss) before income taxes
1,295,674
8,721,035
( 19,026,138 )
( 19,825,658 )
Income tax expense
73,859
110,525
340,185
231,063
Income/(loss) from continuing operations
1,221,815
8,610,510
( 19,366,323 )
( 20,056,721 )
(Loss)/income from discontinued operations, net of tax
( 314,767 )
26,969
( 282,776 )
( 240,319 )
Net income/(loss)
907,048
8,637,479
( 19,649,099 )
( 20,297,040 )
Less net income in noncontrolling interest
-
-
-
( 180,152 )
Net income/(loss) attributable to Cemtrex, Inc. stockholders
$ 907,048
$ 8,637,479
$ ( 19,649,099 )
$ ( 20,116,888 )
Income/(loss) per share - Basic
Continuing Operations
$ 0.12
$ 72.19
$ ( 3.11 )
$ ( 215.24 )
Discontinued Operations
$ ( 0.03 )
$ 0.23
$ ( 0.05 )
$ ( 2.60 )
Income/(loss)
per share - Diluted
Continuing
Operations
$
0.11
$
19.51
$
( 2.97
)
$
( 48.11
)
Discontinued
Operations
$
( 0.03
)
$
0.06
$
( 0.04
)
$
( 0.58
)
Weighted Average Number of Shares-Basic
9,946,752
118,972
6,247,421
92,450
Weighted Average Number of Shares-Diluted
10,237,983
440,146
6,538,652
413,624
The accompanying notes are an integral
part of these unaudited condensed consolidated financial statements.
4
Condensed
Consolidated Statements of Comprehensive Income/(Loss)
(Unaudited)
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
For the three months ended
For the six months ended
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
Other comprehensive loss
Net income/(loss)
$ 907,048
$ 8,637,479
$ ( 19,649,099 )
$ ( 20,297,040 )
Foreign currency translation gain/(loss)
687,749
( 423,482 )
( 31,736 )
( 554,921 )
Comprehensive income/(loss)
1,594,797
8,213,997
( 19,680,835 )
( 20,851,961 )
Less net loss in noncontrolling interest
-
-
-
( 180,152 )
Comprehensive income/(loss) attributable to Cemtrex, Inc. stockholders
$ 1,594,797
$ 8,213,997
$ ( 19,680,835 )
$ ( 20,671,809 )
The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
Cemtrex,
Inc. and Subsidiaries
Condensed
Consolidated Statement of Stockholders’ Equity
(Unaudited)
Number of
Shares
Amount
Number of
Shares
Amount
Number of
Shares
Amount
Paid-in
Capital
Accumulated
Deficit
Preferred Stock
Comprehensive
Income
Stockholders’
Equity
Preferred Stock Series 1
Par Value $0.001
Preferred Stock Series C
Par Value $0.001
Common Stock
Par Value $0.001
Additional
Treasury Stock, 64,100 shares of Series 1
Accumulated
other
Cemtrex
Number of
Shares
Amount
Number of
Shares
Amount
Number of
Shares
Amount
Paid-in
Capital
Accumulated
Deficit
Preferred Stock
Comprehensive
Income
Stockholders’
Equity
Balance at September 30, 2025
2,705,327
$ 2,705
50,000
$ 50
830,606
$ 831
$ 105,668,565
$ ( 99,397,741 )
$ ( 148,291 )
$ 2,591,340
$ 8,717,459
Foreign currency translation loss
( 719,485 )
( 719,485 )
Dividends paid in Series 1 preferred shares
135,592
136
( 136 )
-
Shares issued to pay debt
3,000,296
3,001
19,639,282
19,642,283
Exercise of Series A warrants
29,943
30
211,068
211,098
Exercise of Series B warrants
2,316,480
2,317
15,802,537
15,804,854
Shares issued in offering
2,355,556
2,356
5,988,171
5,990,527
Issuance of roundup shares
67,671
66
( 66 )
-
Net loss
-
( 20,556,147 )
-
( 20,556,147 )
Balance at December 31, 2025
2,840,919
$ 2,841
50,000
$ 50
8,600,552
$ 8,601
$ 147,309,421
$ ( 119,953,888 )
$ ( 148,291 )
$ 1,871,855
$ 29,090,589
Foreign currency translation gain
687,749
687,749
Exercise of Series B warrants
8,030
8
23,841
23,849
Shares issued in offering
1,469,507
1,469
3,998,531
4,000,000
Net income
-
-
907,048
-
907,048
Balance at March 31, 2026
2,840,919
$ 2,841
50,000
$ 50
10,078,089
$ 10,078
$ 151,331,793
$ ( 119,046,840 )
$ ( 148,291 )
$ 2,559,604
$ 34,709,235
The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements .
6
Cemtrex,
Inc. and Subsidiaries
Condensed
Consolidated Statement of Stockholders’ Equity (Continued)
(Unaudited)
Number of Shares
Amount
Number of Shares
Amount
Number of Shares
Amount
Paid-in
Capital
Accumulated
Deficit
Series 1 Preferred Stock
Comprehensive
Income
Stockholders’
Equity
controlling
interest
Preferred Stock Series 1
Par Value $0.001
Preferred Stock Series C
Par Value $0.001
Common Stock
Par Value $0.001
Additional
Treasury Stock, 64,100 shares of
Accumulated
other
Cemtrex
Non-
Number of Shares
Amount
Number of Shares
Amount
Number of Shares
Amount
Paid-in
Capital
Accumulated
Deficit
Series 1 Preferred Stock
Comprehensive
Income
Stockholders’
Equity
controlling
interest
Balance at September 30, 2024
2,456,827
$ 2,457
50,000
$ 50
946
$ 1
$ 73,262,549
$ ( 71,355,386 )
$ ( 148,291 )
$ 2,949,297
$ 4,710,677
$ 250,165
Foreign currency translation loss
( 131,439 )
( 131,439 )
Share-based compensation
4,087
4,087
Dividends paid in Series 1 preferred shares
123,167
123
( 123 )
-
Exercise of Series A warrants
88,492
89
21,515,688
21,515,777
Exercise of Series B warrants
22,244
22
1,095,709
1,095,731
Issuance of roundup shares
7,299
7
( 7 )
-
Loss attributable to noncontrolling interest
-
( 180,152 )
Net loss
-
( 28,754,367 )
-
( 28,754,367 )
Balance at December 31, 2024
2,579,994
$ 2,580
50,000
$ 50
118,981
$ 119
$ 95,877,903
$ ( 100,109,753 )
$ ( 148,291 )
$ 2,817,858
$ ( 1,559,534 )
$ 70,013
Foreign currency translation loss
( 423,482 )
( 423,482 )
Share-based compensation
3,096
3,096
Rounding shares
1
-
Elimination of non-controlling interest
70,013
70,013
( 70,013 )
Net income
-
-
8,637,479
-
8,637,479
Balance at March 31, 2025
2,579,994
2,580
50,000
50
118,982
119
95,880,999
( 91,402,261 )
( 148,291 )
2,394,376
6,727,572
-
The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
7
Cemtrex,
Inc. and Subsidiaries
Condensed
Consolidated Statements of Cash Flows
(Unaudited)
Cash Flows from Operating Activities
2026
2025
For the six months ended
March 31,
Cash Flows from Operating Activities
2026
2025
Net loss
( 19,649,099 )
( 20,297,040 )
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization
1,015,907
648,025
(Gain)/loss on disposal of property and equipment
( 1,007 )
19,668
Noncash lease expense
580,751
461,490
Interest on finance leases
496
-
Loss on marketable securities
69,552
-
Credit loss (recovery)/expense
( 2,409 )
10,572
Loss on write-off of related party receivables
215,779
-
Contract modification - related party
-
280,545
Share-based compensation
-
7,183
Bargain purchase gain
( 2,068,047 )
-
Write-off of demonstration equipment
441,624
-
Interest expense paid in equity shares
11,798,283
-
Accrued interest on notes payable
341,982
530,404
Non-cash royalty income
( 243,525 )
( 71,464 )
Amortization of original issue discounts on notes payable
221,875
16,667
Loan origination costs
25,000
5,000
Receipt of SOL from staking
( 31,683 )
-
Non-cash transaction fees
6,884
-
Unrealized loss on digital assets
1,098,441
-
Loss on exercise of warrant liabilities
4,658,582
15,796,105
Changes in fair value of warrant liability
( 2,285,811 )
5,312,838
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:
Trade receivables
1,014,607
( 1,536,888 )
Trade receivables - related party
35,160
66,057
Inventory
142,207
851,764
Contract assets
( 566,550 )
( 171,413 )
Prepaid expenses and other current assets
( 492,520 )
( 569,401 )
Other assets
15,263
173,497
Accounts payable
( 696,851 )
( 518,330 )
Sales tax payable
( 25,121 )
( 69,054 )
Operating lease liabilities
( 582,108 )
( 464,886 )
Deposits from customers
140,401
( 225,560 )
Accrued expenses
( 586,966 )
972,123
Contract liabilities
160,792
670,221
Deferred revenue
( 475,112 )
( 266,217 )
Income taxes payable
412,260
( 38,617 )
Other liabilities
517
7,243
Net cash (used in)/provided by operating activities
( 5,310,446 )
1,600,532
Cash Flows from Investing Activities
Purchase of property and equipment
( 336,782 )
( 1,359,963 )
Proceeds from sale of property and equipment
19,592
13,511
Royalties on related party revenues
40,000
10,000
Purchase of marketable securities
( 5,100,000 )
-
Acquisitions, net of cash acquired
( 7,594,695 )
-
Investment in digital assets
( 1,000,567 )
-
Investment in MasterpieceVR
-
( 100,000 )
Net cash used by investing activities
( 13,972,452 )
( 1,436,452 )
Cash Flows from Financing Activities
Proceeds on revolving line of credit
10,511,864
18,925,223
Payments on revolving line of credit
( 12,048,307 )
( 19,182,809 )
Payments on debt
( 250,767 )
( 240,510 )
Finance lease liabilities
( 6,897 )
Payments on Paycheck Protection Program Loans
-
( 20,247 )
Proceeds from notes payable
7,000,000
500,000
Proceeds from warrant exercises
5,675,332
1,050,597
Proceeds from offerings
10,000,000
-
Expenses on offerings
( 9,473 )
-
Net cash provided by financing activities
20,871,752
1,032,254
Effect of currency translation
( 25,777 )
( 550,693 )
Net increase in cash, cash equivalents, and restricted cash
1,588,854
1,196,334
Cash, cash equivalents, and restricted cash at beginning of period
6,347,041
5,420,392
Cash, cash equivalents, and restricted cash at end of period
$ 7,910,118
$ 6,066,033
Balance Sheet Accounts Included in Cash, Cash
Equivalents, and Restricted Cash
March 31, 2026
March 31, 2025
Cash and cash equivalents
$ 6,567,030
$ 4,538,405
Restricted cash
1,343,088
1,527,628
Total cash, cash equivalents, and restricted cash
$ 7,910,118
$ 6,066,033
The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
8
Cemtrex,
Inc. and Subsidiaries
Condensed
Consolidated Statements of Cash Flows (Continued)
(Unaudited)
Supplemental Disclosure of Cash Flow Information:
2026
2025
For the six months ended
March 31,
Supplemental Disclosure of Cash Flow Information:
2026
2025
Cash paid during the period for interest
$ 323,938
$ 389,840
Cash paid during the period for income taxes, net of refunds
$ 107,621
$ 269,680
Supplemental Schedule of Non-Cash Investing and Financing Activities
Shares issued to pay notes payable
$ 19,642,283
$ -
Noncash dividends
$ 136
$ 123
Financing of Building Purchase
$ 3,920,000
$ -
Financing of Acquisitions
$ 600,000
$ -
Noncash recognition of new leases
$ 750,580
$ 204,726
Series A Warrant Exercises
$ 211,098
$ 21,515,777
Series B Warrant Exercises
$ 15,828,703
$ -
The
accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
9
Cemtrex,
Inc. and Subsidiaries
NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE
1 – ORGANIZATION AND PLAN OF OPERATIONS
Cemtrex
was incorporated in 1998 in the state of Delaware and has evolved through strategic acquisitions and internal growth into a leading multi-industry
company. Unless the context requires otherwise, all references to “we”, “our”, “us”, “Company”,
“registrant”, “Cemtrex” or “management” refer to Cemtrex, Inc. and its subsidiaries.
The
Company’s reporting segments consist of Security, Industrial Services, and Aerospace and Defense. Additionally, the Company’s
operational structure also reports unallocated corporate expenses.
Security
Cemtrex’s
Security segment operates under the brand of its subsidiary, Vicon Industries, Inc. (“Vicon”), which provides end-to-end
security solutions to meet the toughest corporate, industrial, and governmental security challenges. Vicon’s products include browser-based
video monitoring systems and analytics-based recognition systems, cameras, servers, and access control systems for every aspect of security
and surveillance in industrial and commercial facilities, federal prisons, hospitals, universities, schools, and federal and state government
offices. Vicon provides innovative, mission critical security and video surveillance solutions utilizing Artificial Intelligence (AI)
based data algorithms.
Industrial
Services
Cemtrex’s
Industrial Services segment operates under the brand, Advanced Industrial Services (“AIS”), which offers single-source expertise
and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers.
AIS installs high precision equipment in a wide variety of industrial markets like automotive, printing & graphics, industrial automation,
packaging, and chemicals, among others. AIS is a leading provider of reliability-driven maintenance and contracting solutions for machinery,
packaging, printing, chemical, and other manufacturing markets. We help customers seeking to achieve greater plant and asset utilization
and efficiency by cutting costs and increasing production from existing assets, including small projects to major capital investments,
turnarounds, maintenance, specialty welding services, and high-quality scaffolding and platforms.
Aerospace
and Defense
Cemtrex’s
Aerospace and Defense segment operates under the brand Invocon, Inc., which offers designing, manufacturing, and supporting advanced
instrumentation, wireless sensing, and telemetry systems deployed across satellites, launch vehicles, target missiles, and space-based
platforms. Its technologies support numerous government and prime contractor programs, including multiple Space Shuttle and International
Space Station systems, and the company maintains long-standing relationships across the Missile Defense Agency and leading aerospace
and defense primes.
Common
Stock Reverse Stock Split
On
October 2, 2024, November 26, 2024, and September 29, 2025, the Company completed 60:1 , 35:1 , and 15:1 respectively, reverse stock split
on its common stock. All share and per share data have been retroactively adjusted for the reverse splits.
Acquisitions
The Company accounts for business combinations are using the acquisition method. The consideration transferred is measured at fair value,
which is calculated as the sum of the acquisition-date fair values of the assets transferred, liabilities incurred, and equity interests
issued. Acquisition-related costs are expensed as incurred. Identifiable assets acquired and liabilities assumed are measured at their
acquisition-date fair values.
On
January 8, 2026, the Company completed the acquisition of Invocon, Inc. (“Invocon”). As a result of the transaction,
Invocon became a wholly owned subsidiary of the Company. The purchase price of $ 7,060,000
was paid in cash at closing. Invocon will be the launch of the Company’s Aerospace and Defense segment with reporting results
beginning in the second quarter of fiscal year 2026. This acquisition is part of the Company’s strategy to grow through strategic acquisitions in stable market
sectors.
10
The
purchase price allocation presented below is still preliminary but has been developed based on an estimate of fair values of Invocon’s
identifiable tangible and intangible assets acquired and liabilities assumed as of January 8, 2026. The final allocation of the purchase
price will be determined within one year from the closing date of the Invocon acquisition.
The acquisition of Invocon was accounted for as a business combination
under ASC 805 using the acquisition method of accounting. The assets and liabilities acquired, affected for adjustments to reflect fair
values assigned to assets purchased and liabilities assumed, and results of operations, are included in the Company’s condensed
consolidated financial statements from the Invocon acquisition date.
The Company determined that developed technology was the primary intangible acquired. Under ASC 820-10-55-3A, fair value should reflect
market participant assumptions and the asset’s ability to generate cash flows, supporting an income approach and also states the
Multi-Period Excess Earnings Method (“MPEEM”) is typically applied when the subject intangible asset is the primary driver
of earnings. Because the developed technology is the primary driver of earnings, the MPEEM appropriately isolates its economic contribution
after deducting contributory asset charges. Significant assumptions utilized included projected cash flows, royalty
rates, risk free rate commensurate with the period to determine the value of developed software and tradenames.
The
consideration transferred and preliminary allocation of Invocon’s tangible and intangible assets and liabilities, are as follows:
SCHEDULE OF CONSIDERATION TRANSFERRED AND PRELIMINARY ALLOCATION OF TANGIBLE AND INTANGIBLE ASSETS AND LIABILITIES
Preliminary
Consideration Transferred:
Cash
$ 7,060,000
Less cash acquired
( 389,193 )
Total consideration transferred
$ 6,670,807
Purchase Price Allocation:
Accounts receivable
98,981
Prepaid expenses
71,661
Contract assets
127,465
Property and equipment
779
Right-of-use assets
650,650
Intangible assets
3,130,000
Accounts payable
( 158,056 )
Accrued expenses
( 338,531 )
Contract liabilities
( 239,286 )
Lease liabilities
( 650,650 )
Goodwill
3,977,794
Total consideration transferred
$ 6,670,807
The
pro forma summary below presents the results of operations as if the Invocon acquisition occurred on October 1, 2024. Proforma adjustments
for the three and six months ended March 31, 2026, includes $ ( 2,214 ) ,
and $ 393,750
respectively, of interest expense from the Company’s $ 7,025,000
note
payable used to fund the transaction, income tax benefit of $ 2,663 ,
and $ 148,251
of
amortization on recognized intangible assets for the three months ended March 31, 2026, and six months ended March 31, 2026. Proforma
adjustments for the three and six months ended March 31, 2025, includes $ 165,475 ,
and $ ( 393,750 ) ,
respectively, of interest expense from the Company’s $ 7,025,000
note
payable used to fund the transaction, $ 25,000
of
legal fees related to the acquisition, $ 148,251
of
amortization on recognized intangible assets and income tax expense of $ 727
for
the three months ended March 31, 2025, $ 321,502
of
amortization on recognized intangible assets and $ 171,604
of
income tax expense for the six months ended March 31, 2025. The pro forma summary uses estimates and assumptions based on information
available at the time. Management believes the estimates and assumptions to be reasonable; however, actual results may have differed
significantly from this proforma financial information. The pro forma information does not reflect any cost savings, operating synergies
or revenue enhancements that might have been achieved from combining the operations. The unaudited pro forma summary is provided for
illustrative purposes only and does not purport to represent the Company’s actual consolidated results of operations had the acquisition
been completed as of the date presented, nor should it be considered indicative of Cemtrex’s future consolidated results of operations.
SCHEDULE OF PRO FORMA STATEMENTS OF OPERATIONS
Unaudited
Unaudited
Unaudited
Unaudited
For the three
months ended
For the three
months ended
For the six
months ended
For the six
months ended
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
Revenues
$ 18,865,872
$ 28,309,447
$ 34,999,183
$ 42,943,216
Net income/(loss)
$ 408,543
$
8,226,096
$ ( 20,543,568 )
$ ( 21,150,249 )
On
February 5, 2026, the Company, through its subsidiary AIS, acquired substantially all the assets of Richland Industries LLC (“Richland”),
an industrial services and fabrication company located in Tennessee. In connection with the transaction, AIS established a new subsidiary,
AIS Tennessee, Inc (“AIS – TN”), as part of the Company’s Industrial Services Segment. The acquisition was made to bring in vital services that AIS had previously
outsourced. The purchase price of
$ 600,000 was paid via a note payable issued by Fulton Bank. This note carries interest of 6.09 % and matures on February 1, 2031 . In addition,
the Company purchased Richland’s primary facility for $ 4,900,000 via a $ 3,920,000 mortgage issued by Fulton Bank and the balance
including taxes, closing costs, and fees in cash. This mortgage has carries interest of SOFR plus 2.75 % and matures on February 1, 2041 .
11
The acquisition of Richland was accounted for as a business combination
under ASC 805 using the acquisition method of accounting. The assets and liabilities acquired, affected for adjustments to reflect fair
values assigned to assets purchased and liabilities assumed, and results of operations, are included in the Company’s condensed
consolidated financial statements from the Richland acquisition date.
The
purchase price allocation presented below is still preliminary but has been developed based on an estimate of fair values of Richland
identifiable tangible and intangible assets acquired and liabilities assumed as of February 5, 2026. The final allocation of the purchase
price will be determined within one year from the closing date of the Richland acquisition.
The
consideration transferred and preliminary allocation of AIS - TN tangible and intangible assets and liabilities, are as follows:
Preliminary
Consideration Transferred:
Cash
$ 1,176,593
Note payable to finance acquisition
4,520,000
Less cash acquired
( 252,705 )
Total consideration transferred
$ 5,443,888
Purchase Price Allocation:
Accounts receivable
1,105,352
Prepaid expenses
46,596
Inventory
308,247
Contract assets
534,390
Property and equipment
7,443,593
Right-of-use assets
76,021
Other assets
4,188
Accounts payable
( 606,439 )
Letter of credit
( 396,022 )
Accrued expenses
( 122,522 )
Contract liabilities
( 293,251 )
Lease liabilities
( 338,218 )
Long-term debt
( 250,000 )
Bargain purchase gain
( 2,068,047 )
Total consideration transferred
$ 5,443,888
The
pro forma summary below presents the results of operations as if the Richland acquisition occurred on October 1, 2024. Proforma adjustments for the three and six months ended March 31, 2026,
includes $ 10,008 , and $ 13,976 , respectively, of interest expense from the Company’s 600,000 note payable used to fund the transaction,
and income tax benefit of $ 22,537 for the three months ended March 31, 2026, and $ 114,432 of income tax benefit for the six months ended
March 31, 2026. Proforma adjustments
for the three and six months ended March 31, 2025, includes $ 9,347 , and $ 18,564 , respectively, of interest expense from the Company’s
600,000 note payable used to fund the transaction, and income tax benefit of $ 37,364 for the three months ended March 31, 2025, and $ 63,230 of income tax expense
for the six months ended March 31, 2025. The pro forma summary uses estimates and assumptions based on information available at the time.
Management believes the estimates and assumptions to be reasonable; however, actual results may have differed significantly from
this proforma financial information. The pro forma information does not reflect any cost savings, operating synergies or revenue enhancements
that might have been achieved from combining the operations. The unaudited pro forma summary is provided for illustrative purposes only
and does not purport to represent the Company’s actual consolidated results of operations had the acquisition been completed as
of the date presented, nor should it be considered indicative of Cemtrex’s future consolidated results of operations.
Unaudited
Unaudited
Unaudited
Unaudited
For the three
months ended
For the three
months ended
For the six
months ended
For the six
months ended
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
Revenues
$ 18,511,558
$ 30,403,614
$ 37,031,105
$ 47,451,363
Net(loss)/income
$ 380,868
$ 8,316,781
$ ( 20,517,585 )
$ ( 21,716,395 )
Going
Concern Considerations
The
accompanying unaudited condensed consolidated financial statements of the Company have been prepared assuming the Company will continue
as a going concern and in accordance with generally accepted accounting principles in the United States of America. The going concern
basis of presentation assumes that the Company will continue in operation one year after the date these financial statements are issued
and will be able to realize its assets and discharge its liabilities and commitments in the normal course of business. Pursuant to the
requirements of the ASC 205, management must evaluate whether there are conditions or events, considered in the aggregate, which raise
substantial doubt about the Company’s ability to continue as a going concern for one year from the date these financial statements
are issued.
12
This
evaluation does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented
or are not within control of the Company as of the date the financial statements are issued. When substantial doubt exists under this
methodology, management evaluates whether the mitigating effect of its plans sufficiently alleviates substantial doubt about the Company’s
ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it
is probable that the plans will be effectively implemented within one year after the date that the financial statements are issued, and
(2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about
the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued.
The
Company has incurred substantial net losses attributable to Cemtrex, Inc. stockholders of $ 28,112,368
and $ 7,229,491
for fiscal years 2025 and 2024, respectively and a net losses attributable to Cemtrex, Inc. stockholders of $ 19,649,099
for the six months ended March 31, 2026, and has debt obligations over the next fiscal year of $ 10,806,016
that raise substantial doubt with respect to the Company’s ability to continue as a going concern.
While
the Company’s losses and current debt indicate a substantial doubt regarding the Company’s ability to continue as a
going concern, the Company has historically, from time to time, satisfied and may continue to satisfy certain short-term liabilities
through the issuance of common stock, thus reducing our cash requirement to meet our operating needs. These transactions add
additional significant non-operational expenses which are non-cash in nature. The Company has $ 7,910,118
in cash and cash equivalents and restricted cash as of March 31, 2026. Additionally, the Company has (i) secured a line of credit
for its Vicon brand to fund operations, which as of March 31, 2026, has available capacity of approximately $ 1,100,000 ,
(ii) continually reevaluate our pricing model on the Company’s Vicon brand to improve margins on those products, (iii) raised
$ 5,675,332
through the exercise of our Series B warrants during the six months ended March 31, 2026 (iv) raised $ 10,000,000
in gross proceeds in equity offering during the six months ended March 31, 2026 (v) Invested approximately $ 5,000,000 of the Company’s surplus cash in various marketable securities to generate
income on those investments. In the event additional capital is raised through
equity offerings and/or debt is satisfied with equity, it may have a dilutive effect on our existing stockholders. While the Company
believes these plans, if successful, would be sufficient to meet the capital demands of the Company’s current operations for
at least the next twelve months, there is no guarantee that the Company will succeed.
Overall,
there is no guarantee that cash flow from our existing or future operations and any external capital that we may be able to raise will
be sufficient to meet our working capital needs. The Company currently does not have adequate cash or available liquidity/available capacity
on our lines of credit to meet our long-term needs and our above plans in the short term may prove to be inadequate to continue as a
going concern. Thus, despite our cash on hand, our ability to draw on our credit line, or changes to our pricing models, and other safeguards,
we may be unable to meet our obligations as they become due over the next twelve months beyond the issuance date. The unaudited condensed
consolidated financial statements do not include any adjustments relating to this uncertainty.
NOTE
2 – INTERIM STATEMENT PRESENTATION
Basis
of Presentation and Use of Estimates
The
accompanying unaudited condensed consolidated financial information should be read in conjunction with the audited consolidated financial
statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the year ended September 30, 2025.
The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles in the Unites States (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and
Article 10 of Regulation S-X pursuant to the requirements of the U.S. Securities and Exchange Commission (‘SEC”). Accordingly,
they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial
statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair
presentation have been included. The results of operations for the interim periods are not necessarily indicative of the results of operations
for the entire year.
13
The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities as of the date of the condensed consolidated financial statements, the disclosure of contingent
assets and liabilities in the condensed consolidated financial statements and the accompanying notes, and the reported amounts of revenues,
expenses and cash flows during the periods presented. Actual amounts and results could differ from those estimates. The estimates and
assumptions the Company makes are based on historical factors, current circumstances and the experience and judgment of the Company’s
management. The Company evaluates its estimates and assumptions on an ongoing basis.
Significant
Accounting Policies
Note
2 of the Notes to Consolidated Financial Statements, included in the annual report on Form 10-K for the year ended September 30, 2025,
includes a summary of the significant accounting policies used in the preparation of the unaudited condensed consolidated financial statements.
Recently
Adopted Accounting Pronouncements
In
December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which requires
public entities to disclose consistent categories and greater disaggregation of information in the rate reconciliation and for income
taxes paid. It also includes certain other amendments to improve the effectiveness of income tax disclosures. The guidance is effective
for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted. The Company adopted
this standard on October 1, 2025. The Company does not believe that this will have a material effect on the unaudited condensed consolidated
financial statements.
Recently
Issued Accounting Pronouncements Not Yet Effective
In
October 2023, the FASB issued ASU 2023-06, Disclosure Improvements: Codification Amendments in Response to the SEC’s Disclosure
Update and Simplification Initiative, to amend certain disclosure and presentation requirements for a variety of topics within the Accounting
Standards Codification (“ASC”). These amendments align the requirements in the ASC to the removal of certain disclosure requirements
set out in Regulation S-X and Regulation S-K, announced by the SEC. The effective date for each amended topic in the ASC is the date
on which the SEC’s removal of the related disclosure requirement from Regulation S-X or Regulation S-K becomes effective. Early
adoption is prohibited. The Company does not anticipate that the ASU will have a material effect on the Company’s unaudited financial
statements and related disclosures.
In
November 2024, the FASB issued ASU 2024-03, “Income Statement (Topic 220): Reporting Comprehensive Income - Expense Disaggregation
Disclosures, Disaggregation of Income Statement Expenses”, that requires public companies to disclose, in interim and reporting
periods, additional information about certain expenses in the financial statements. ASU 2024-03 is effective for annual periods beginning
after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted and is effective
on either a prospective basis or retrospective basis. The Company is currently assessing the potential impacts of adoption on the unaudited
condensed consolidated financial statements.
In
November 2024, the FASB issued ASU 2024-04, “Debt with Conversion and Other Options (Subtopic 470-20), which clarifies the requirements
for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. ASU 2024-04
is effective for annual periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods.
Early adoption is permitted for all entities that have adopted the amendments in Update 2020-06. Adoption can be on a prospective or
retrospective basis. The Company is currently in the process of evaluating the impact of adoption on the unaudited condensed consolidated
financial statements.
In
July 2025, the FASB issued ASU 2025-05, Financial Instruments—Credit Losses (Topic 326). This guidance contains amendments that
provide decision-useful information to investors and other financial statement users while reducing the time and effort necessary to
analyze and estimate credit losses for current accounts receivable and current contract assets. The amendments will be effective for
annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early
adoption is permitted in both interim and annual reporting periods in which financial statements have not yet been issued or made available
for issuance. The Company is currently evaluating the impact of ASU 2025-05 on its unaudited condensed consolidated financial statements
and related disclosures.
14
In
December 2025, the FASB issued ASU 2025-11 - Interim Reporting (“ASU 2025-11”) which is intended to improve the navigability
of the guidance in ASC 270, Interim Reporting, and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if
it provides interim financial statements and notes in accordance with GAAP. ASU 2025-11 also addresses the form and content of such financial
statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of
the last annual reporting period that have a material impact on the entity. ASU 2025-11 is effective for interim reporting periods within
annual reporting periods beginning after December 15, 2027, and early adoption is permitted. The Company is currently evaluating the
impact the adoption of ASU 2025-11 may have on the Company’s unaudited consolidated financial statements.
In
April 2026, the FASB issued Accounting Standards Update No. 2026-01, Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends
on Equity-Classified Preferred Stock . The amendments in this Update clarify that PIK dividends on equity-classified preferred stock
should be initially measured at the amount specified in the agreement, generally calculated by multiplying the PIK dividend rate by the
liquidation value of the preferred stock outstanding. The standard is effective for the Company for fiscal years beginning after December
15, 2026. The Company is currently evaluating the impact the adoption of ASU 2026-01 may have on the Company’s unaudited consolidated
financial statements.
The
Company does not believe that any other recently issued but not yet effective accounting pronouncements, if adopted, would have a material
effect on the accompanying unaudited condensed consolidated financial statements.
Correction
of an Immaterial Error in Previously Issued Financial Statements
Subsequent
to the issuance of our financial statements for the quarter ended March 31, 2026, an immaterial error was identified and has been corrected
in our historical information related to the net income/(loss) in noncontrolling interest. On February 24, 2025, the Company filed a
Certificate of Amendment to the Certificate of Incorporation for Vicon Industries Inc. This amendment effected a reverse stock split
which exchanged 98,521 for 6 shares of common stock and reduces the number of authorized common shares from 75,000,000 to 15,000 .
The
effects of the correction to the individual effected line items in our Consolidated Statement of Operations are as follows:
SCHEDULE OF EFFECTS OF CORRECTION TO CONSOLIDATED STATEMENT OF OPERATIONS
As previously reported
Corrections
As corrected
For the three months ended March 31, 2025
As previously reported
Corrections
As corrected
Less net income/(loss) in noncontrolling interest
254,537
( 254,537 )
-
Net income/(loss) attributable to Cemtrex, Inc. stockholders
$ 8,382,942
$ 254,537
$ 8,637,479
As previously reported
Corrections
As corrected
For the six months ended March 31, 2025
As previously reported
Corrections
As corrected
Less net income/(loss) in noncontrolling interest
74,385
( 254,537 )
( 180,152 )
Net income/(loss) attributable to Cemtrex, Inc. stockholders
$ ( 20,371,425 )
$ 254,537
$ ( 20,116,888 )
15
NOTE
3 – REVENUE
The
following table illustrates the approximate disaggregation of the Company’s revenue based off timing of revenue recognition for
the three and six months ended March 31, 2026, and 2025:
SCHEDULE OF DISAGGREGATION OF REVENUE RECOGNITION
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
For the three months ended
For the six months ended
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
Over time
71 %
40 %
71 %
49 %
Point-in-time
29 %
60 %
29 %
51 %
Revenue performance obligation percentage
29 %
60 %
29 %
51 %
NOTE
4 – INCOME/(LOSS) PER COMMON SHARE
Basic
net loss per common share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during
the period. Diluted net loss per common share is computed by dividing net income by the weighted average number of shares of common stock
and potentially dilutive outstanding shares of common stock during the period to reflect the potential dilution that could occur from
common shares issuable through contingent share arrangements, stock options, and warrants. For the three and six months ended March 31,
2026, and 2025, the following items were excluded from the computation of diluted net loss per common share as their effect is anti-dilutive:
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER COMMON SHARE AS ANTI-DILUTIVE EFFECT
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
For the three months ended
For the six months ended
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
Options
7
7
7
7
Warrants
1,068,339
3,318,556
1,068,339
3,318,556
Anti-dilutive shares
1,068,339
3,318,556
1,068,339
3,318,556
For
the three and six months ended March 31, 2026, and 2025, loss per share basic and diluted for continuing operations are calculated as
follows:
SCHEDULE OF LOSS PER SHARE BASIC AND DILUTED FOR CONTINUING OPERATIONS
2026
2025
2026
2025
For the three months ended
For the six months ended
March 31,
March 31,
2026
2025
2026
2025
Net income/(loss)
$ 907,048
$ 8,637,479
$ ( 19,649,099 )
$ ( 20,297,040 )
Less(loss)/income from discontinued operations, net of
tax
( 314,767 )
26,969
( 282,776 )
( 240,319 )
Less net loss in noncontrolling interest
-
-
-
( 180,152 )
Preferred stock dividends
46,918
21,949
46,918
21,949
Net income/(loss) applicable to common shareholders
1,174,983
8,588,561
( 19,413,241 )
( 19,898,158 )
Weighted Average Number of Shares-Basic
9,946,752
118,972
6,247,421
92,450
Weighted Average Number of Shares-Diluted
10,237,983
440,146
6,538,652
413,624
Loss per share - Basic - Continuing Operations
$ 0.12
$ 72.19
$ ( 3.11 )
$ ( 215.24 )
Loss per share - Diluted - Continuing Operations
$ 0.11
$ 19.51
$ ( 2.97 )
$ ( 48.11 )
Loss per share - Basic - Discontinued Operations
$ ( 0.03
)
$ 0.23
$ ( 0.05 )
$ ( 2.60 )
Loss per share - Diluted - Discontinued Operations
$ ( 0.03
)
$ 0.06
$ ( 0.04
)
$ ( 0.58
)
In
accordance with ASC 260-45-13, the common shares underlying the Series A Warrants under the alternative cashless exercise have been included
in the calculation of the weighted average shares.
NOTE
5 – SEGMENT INFORMATION
The
Company reports and evaluates financial information for three reportable segments: the Security segment, Industrial Services segment,
and the Aerospace and Defense segment. The Chief Operating Decision Maker (“CODM”) for all segments is Saagar Govil, the
CEO of the Company.
Unallocated
corporate expenses mainly relate to payroll and benefits for corporate officers, investor relation expenses, accounting expenses related
to audit and taxes, legal expenses related to corporate matters, interest expense on notes payable, and Series A and B Warrants transaction
losses.
16
The
following tables summarize the Company’s reportable segment information and unallocated corporate expenses:
SCHEDULE OF SEGMENT INFORMATION
Security
Industrial Services
Aerospace and Defense
Corporate
Consolidated
Three months ended March 31, 2026
Reportable Segments
Security
Industrial Services
Aerospace and Defense
Corporate
Consolidated
External revenues
$ 5,776,557
$ 11,038,046
$ 1,232,592
$ 14,172
$ 18,061,367
Cost of revenues
3,245,863
7,256,523
711,777
-
11,214,163
Gross profit
$ 2,530,694
$ 3,781,523
$ 520,815
$ 14,172
$ 6,847,204
Operating expenses
General and administrative
3,305,771
2,773,590
762,072
1,115,105
7,956,538
Depreciation and amortization
65,525
302,070
148,250
-
515,845
Research and development
521,579
-
25,279
-
546,858
Operating (loss)/income
$ ( 1,362,181 )
$ 705,863
$ ( 414,786 )
$ ( 1,100,933 )
$ ( 2,172,037 )
Other income/(expense), net
$ ( 51,468 )
1,967,994
$ -
$ 1,551,185
$ 3,467,711
Security
Industrial Services
Aerospace and Defense
Corporate
Consolidated
Three months ended March 31, 2025
Reportable Segments
Security
Industrial Services
Aerospace and Defense
Corporate
Consolidated
External revenues
$ 16,981,152
$ 10,269,117
$ -
$ -
$ 27,250,269
Cost of revenues
8,177,296
6,907,518
-
-
15,084,814
Gross profit
$ 8,803,856
$ 3,361,599
$ -
$ -
$ 12,165,455
Operating expenses
General and administrative
3,655,756
2,229,023
-
575,661
6,460,440
Depreciation and amortization
85,433
224,869
-
-
310,302
Research and development
777,889
-
-
-
777,889
Operating income/(loss)
$ 4,284,778
$ 907,707
$ -
$ ( 575,661 )
$ 4,616,824
Other (expense)/income, net
$ ( 493,731 )
( 110,145 )
$ -
$ 4,708,087
$ 4,104,211
17
Security
Industrial Services
Aerospace and Defense
Corporate
Consolidated
Six months ended March 31, 2026
Reportable Segments
Security
Industrial Services
Aerospace and Defense
Corporate
Consolidated
External revenues
$ 11,288,085
$ 21,649,202
$ 1,232,592
$ 24,799
$ 34,194,678
Cost of revenues
6,596,623
14,417,208
711,777
-
21,725,608
Gross profit
$ 4,691,462
$ 7,231,994
$ 520,815
$ 24,799
$ 12,469,070
Operating expenses
General and administrative
7,909,694
4,563,329
762,072
2,324,733
15,559,828
Depreciation and amortization
145,561
545,335
148,250
-
839,146
Research and development
1,023,014
-
25,279
-
1,048,293
Operating (loss)/income
$ ( 4,386,807 )
$ 2,123,330
$ ( 414,786 )
$ ( 2,299,934 )
$ ( 4,978,197 )
Other (expense)/income, net
$ ( 115,642 )
$ 1,918,577
$ -
$ ( 15,850,876 )
$ ( 14,047,941 )
Security
Industrial Services
Aerospace and Defense
Corporate
Consolidated
Six months ended March 31, 2025
Reportable Segments
Security
Industrial Services
Aerospace and Defense
Corporate
Consolidated
External revenues
$ 22,434,851
$ 18,555,317
$ -
$ -
$ 40,990,168
Cost of revenues
10,791,236
12,331,541
-
-
23,122,777
Gross profit
$ 11,643,615
$ 6,223,776
$ -
$ -
$ 17,867,391
Operating expenses
General and administrative
7,415,054
3,990,426
-
1,810,526
13,216,006
Depreciation and amortization
171,456
476,569
-
-
648,025
Research and development
1,667,972
-
-
-
1,667,972
Operating income/(loss)
$ 2,389,133
$ 1,756,781
$ -
$ ( 1,810,526 )
$ 2,335,388
Other (expense)/income, net
$ ( 886,648 )
$ ( 188,371 )
$ -
$ ( 21,086,027 )
$ ( 22,161,046 )
The
following table summarizes the Company’s identifiable assets by segment as of March 31, 2026, and September 30, 2025.
SCHEDULE OF IDENTIFIABLE ASSETS BY SEGMENT
March 31, 2026
September 30, 2025
Identifiable Assets
Security
$ 14,568,187
$ 17,334,365
Industrial Services
34,001,213
25,865,577
Aerospace and Defense
8,466,640
-
Corporate
13,700,334
4,588,334
Total Assets
$ 70,736,374
$ 47,788,276
NOTE
6 – RESTRICTED CASH
A
subsidiary of the Company participates in a consortium in order to self-insure group care coverage for its employees. The plan is administrated
by Benecon Group, and the Company makes monthly deposits in a trust account to cover medical claims and any administrative costs associated
with the plan. Additionally, there was restricted cash in escrow per the purchase agreement with Heisey Mechanical Ltd. Additionally,
there are funds in escrow related to bond requirements on certain public projects and deposit guarantees.
18
The
Company’s restricted cash as of March 31, 2026, and September 30, 2025, are summarized below.
SCHEDULE OF RESTRICTED CASH
March 31, 2026
September 30, 2025
Benecon group
$ 972,865
$ 839,215
Heisey escrow
-
100,000
Bond escrow
304,145
366,319
Deposit guarantees
66,078
67,204
Escrow deposit
66,078
67,204
Restricted cash
$ 1,343,088
$ 1,372,738
NOTE
7 – FAIR VALUE MEASUREMENTS
Fair
value is defined as the price that would be received upon sale of an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date. A three-level hierarchy is applied to prioritize the inputs to valuation techniques
used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).
The
three levels of the fair value hierarchy under the guidance for fair value measurements are described below:
Level
1 — Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity
has the ability to access at the measurement date. Our Level 1 assets include cash equivalents, banker’s acceptances, trading securities,
investments, and investment funds. The Company measures trading securities investments and investment funds at quoted market prices as
they are traded in an active market with sufficient volume and frequency of transactions.
Level
2 — Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for the asset or liability,
either directly or indirectly. If the asset or liability has a specified contractual term, a Level 2 input must be observable for substantially
the full term of the asset or liability.
Level
3 — Level 3 inputs are unobservable inputs for the asset or liability in which there is little, if any, market activity for the
asset or liability at the measurement date. Level 3 assets and liabilities include cost method investments. Quantitative information
for Level 3 assets and liabilities reviewed at each reporting period includes indicators of significant deterioration in the earnings
performance, credit rating, asset quality, business prospects of the investee, and financial indicators of the investee’s ability
to continue as a going concern.
19
The
Company’s fair value liabilities at March 31, 2026, and September 30, 2025, are as follows.
SCHEDULE OF FAIR VALUE OF LIABILITIES
Quoted Prices
Significant
in Active
Other
Significant
Balance
Markets for
Observable
Unobservable
as of
Identical Assets
Inputs
Inputs
March 31,
(Level 1)
(Level 2)
(Level 3)
2026
Assets
Digital assets - SOL
$ 1,085,163
$ -
$ -
$ 1,085,163
Marketable Securities
$ 5,030,448
$ -
$ -
$ 5,030,448
Liabilities
Warrant liabilities
$ 196,823
$ 546,676
$ -
$ 743,499
Quoted Prices
Significant
in Active
Other
Significant
Balance
Markets for
Observable
Unobservable
as of
Identical Assets
Inputs
Inputs
September 30,
(Level 1)
(Level 2)
(Level 3)
2025
Assets
Digital assets - SOL
$ 1,158,238
$ -
$ -
$ 1,158,238
Liabilities
Warrant liabilities
$ 833,854
$ 7,901,343
$ -
$ 8,735,197
Digital
Assets – SOL
On
July 29, 2025, and January 7, 2026, the Company invested $ 998,642 , and 1,000,567 , respectively, in Solana (SOL) and staked our holdings.
SOL is a fungible crypto asset that meets the criteria for an intangible asset, resides on a distributed ledger, is secured by cryptography,
and does not grant enforceable rights to underlying goods or services to its holder. The digital assets were measured at fair value after
acquisition, with changes reported in net income. Staking earnings are recorded as revenue.
Digital
Asset staking allows holders of specific cryptocurrencies to earn rewards for helping to validate blocks of transaction data as it is
submitted to the blockchain network.
The
staking process serves two key purposes:
●
Ensures the accuracy of new information as it is added to the
blockchain.
●
Helps to secure the underlying blockchain network against the
majority of the network taking over control, known as a 51% attack.
The
staking process uses incentives and penalties governed by computer-based rules to encourage honest participation in the network. Stakers
who act within the rules of the protocol receive rewards for their contributions, while those who act dishonestly can face penalties,
such as losing their staked cryptocurrency through a process called slashing. Staking rewards are distributed as newly minted cryptocurrency
units, oftentimes at a proportionate rate to the amount a person stakes. With some proof-of-stake blockchains, depositing more assets
in a staking smart contract increases the chance of being selected to validate blocks. This mechanism is based on the assumption that
those with more “skin in the game” are more likely to act within the best interests of the network because they have more
to lose financially if their assets are slashed (confiscated by the network). However, to avoid favoring wealthier participants, some
protocols incorporate randomness to ensure everyone, including those with smaller stakes, has a chance to earn rewards.
20
Staking
incentives, in the form of additional SOL, are recognized on the date received at the fair market value on that date. There are no lockups
or restrictions on the Company’s digital asset holdings due to staking.
The
Company’s digital assets as of March 31, 2026, and September 30, 2025, are as follows.
SCHEDULE OF DIGITAL ASSETS HOLDINGS
March 31, 2026
September 30, 2025
Units - SOL
13,058
5,549
Cost Per Unit
$ 155.74
$ 181.70
Cost Basis
$ 2,033,595
$ 1,008,229
Fair Value
$ 1,085,163
$ 1,158,238
The
following table is a summary of our digital assets as of March 31, 2026.
SUMMARY OF DIGITAL ASSETS
Fair Value, September 30, 2025
$ 1,158,238
Cash purchase
1,000,567
Receipt of SOL from staking
31,683
Non-cash transaction fees
( 6,884 )
Unrealized loss
( 1,098,441 )
Fair Value, March 31, 2026
$ 1,085,163
Marketable Securities
Marketable securities utilizing Level 1 inputs include active exchange-traded
equity securities and equity index funds, as these securities all have quoted prices in active markets. These marketable securities are
trading securities and are recorded at fair value. Unrealized gains and losses are reported under the caption other income/(expense),
net on the Company’s Condensed Consolidated Statements of Operations.
Warrant
Liabilities
The
value of the Series A Warrants is based on the market value of our common stock on the balance sheet date.
The
fair value of the Series B Warrants is estimated on the balance sheet date using the Black-Scholes model, which requires inputs based
on certain subjective assumptions, including the fair value of the Company’s common shares, expected share price volatility, the
expected term of the award, the risk-free interest rate for a period that approximates the expected term of the option, and the Company’s
expected dividend yield.
At
March 31, 2026, and September 30, 2025, the following inputs were used in the Black-Scholes model.
SCHEDULE OF FAIR VALUE INPUTS USED IN BLACK-SCHOLES MODEL
March 31, 2026
September 30, 2025
Expected term
3.09 Years
3.59 Years
Risk-free interest rate
3.81 %
3.61 %
Expected volatility
185.85 %
178.98 %
Expected dividend yield
0.00 %
0.00 %
Exercise Price
$ 2.25
$ 5.30
21
The
following table summarizes information on warrant liabilities as of March 31, 2026.
SCHEDULE OF WARRANT LIABILITIES ACTIVITY
Series A Warrants
Series B Warrants
Total
Warrant Liabilities at September 30, 2025
$ 833,854
$ 7,901,343
$ 8,735,197
Warrant Liabilities, Beginning balance
$ 833,854
$ 7,901,343
$ 8,735,197
Warrants Issued
-
-
-
Warrants Exercised
( 97,614 )
( 5,608,273 )
( 5,705,887 )
Fair market revaluation
( 539,417 )
( 1,746,394 )
( 2,285,811 )
Warrant Liabilities at March 31, 2026
$ 196,823
$ 546,676
$ 743,499
Warrant Liabilities, Ending balance
$ 196,823
$ 546,676
$ 743,499
NOTE
8 – TRADE RECEIVABLES, NET
Trade
receivables, net consisted of the following:
SCHEDULE OF TRADE RECEIVABLES, NET
March 31, 2026
September 30, 2025
Trade receivables
$ 13,475,565
$ 13,285,839
Allowance for credit losses
( 150,006 )
( 152,415 )
Trade receivables, net
$ 13,325,559
$ 13,133,424
Trade
receivables include amounts due for shipped products and services rendered.
Allowance
for credit losses include estimated losses resulting from the inability of our customers to make the required payments.
NOTE
9 – PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid
expenses and other current assets consisted of the following:
SUMMARY OF PREPAID EXPENSES AND OTHER CURRENT ASSETS
March 31, 2026
September 30, 2025
Prepaid expenses
$ 1,307,009
$ 1,327,463
Prepaid inventory
334,286
81,820
Deferred costs
379,797
132,434
Short-term investments
-
14,715
Prepaid income taxes
146,117
-
Prepaid expenses and other current assets total
$ 2,167,209
$ 1,556,432
NOTE
10 – INVENTORY, NET
Inventory,
net consisted of the following:
SCHEDULE OF INVENTORY, NET
March 31, 2026
September 30, 2025
Raw materials
$ 680,252
$ 609,304
Work in progress
464,337
364,907
Finished goods
5,595,990
5,610,733
Inventory, net
6,740,579
6,584,944
22
The
Company maintained an allowance for obsolete inventories of $ 1,019,828 and $ 1,034,798 at March 31, 2026, and September 30, 2025, respectively.
NOTE
11 – PROPERTY AND EQUIPMENT
Property
and equipment are summarized as follows:
SUMMARY OF PROPERTY AND EQUIPMENT
March 31, 2026
September 30, 2025
Land
$ 1,854,511
$ 945,279
Building and leasehold improvements
8,744,992
4,482,978
Furniture and office equipment
650,194
625,995
Computers and software
2,654,119
2,685,331
Machinery and equipment
16,443,751
13,927,502
Property and equipment, gross
30,347,567
22,667,085
Less: Accumulated depreciation
( 13,806,618 )
( 13,015,089 )
Property and equipment, net
$ 16,540,949
$ 9,651,996
Depreciation
expense for the three months ended March 31, 2026, and 2025, was $ 458,939 and $ 319,507 , respectively, depreciation expense for the six
months ended March 31, 2026, and 2025, was $ 877,126 and $ 666,252 , respectively, and is recorded in cost of revenues and general and administrative
expenses on the Company’s unaudited condensed consolidated statements of operations.
NOTE
12 – GOODWILL AND INTANGIBLE ASSETS
Changes
in the carrying amount of goodwill, by segment, were as follows:
SCHEDULE OF GOODWILL BY SEGMENT
Security
Industrial Services
Aerospace and Defense
Consolidated
Balance at September 30, 2025
$ -
$ 3,708,347
$ -
$ 3,708,347
Impairment /adjustments
-
-
-
-
Acquisitions
-
-
3,977,794
3,977,794
Balance at March 31, 2026
$ -
$ 3,708,347
$ 3,977,794
$ 7,686,141
As
of March 31, 2026, and September 30, 2025, accumulated impairment losses of $ 3,846,475 have been recorded related to the Security segment.
On
January 8, 2026, the Company acquired Invocon, as part of the fair market evaluation for the purchase price accounting, the company recognized
intangible assets in the form of the company trade name and internal developed technologies.
Changes
in the carrying amount of intangible assets, by segment, were as follows:
SCHEDULE OF INTANGIBLE ASSETS BY SEGMENT
Security
Industrial Services
Aerospace and Defense
Consolidated
Balance at September 30, 2025
$ -
$ -
$ -
$ -
Acquisitions
-
-
3,130,000
3,130,000
Amortization
-
-
( 148,250 )
( 148,250 )
Balance at March 31, 2026
$ -
$ -
$ 2,981,750
$ 2,981,750
NOTE
13 – OTHER ASSETS
On
November 13, 2020, and January 19, 2022, Cemtrex made $ 500,000 in investments, on July 18, 2023, and October 5, 2023, made additional
$ 100,000 in investments, and on October 17, 2024, and November 18, 2024, made additional $ 50,000 in investments on each respective date,
via a simple agreement for future equity (“SAFE”) in MasterpieceVR. The SAFE provides that the Company will automatically
receive shares of the entity based on the conversion rate of future equity rounds up to a valuation cap, as defined. MasterpieceVR is
a software company that is developing software for content creation using virtual reality. The investment is included in other assets
in the accompanying unaudited condensed consolidated balance sheet and the Company accounts for this investment and records it at cost.
No impairment has been recorded for the six months ended March 31, 2026, and 2025.
23
Other
assets consisted of the following:
SCHEDULE OF OTHER ASSETS
March 31, 2026
September 30, 2025
Rental deposits
$ 259,619
$ 262,201
Investment in Masterpiece VR
1,300,000
1,300,000
Other deposits
51,249
63,930
Demonstration equipment supplied to resellers
-
441,624
Other assets total
$ 1,610,868
$ 2,067,755
NOTE
14 – ACCRUED EXPENSES
Accrued
expenses consisted of the following:
SCHEDULE OF ACCRUED EXPENSES
March 31, 2026
September 30, 2025
Accrued expenses
$ 1,305,722
$ 442,344
Accrued payroll and payroll taxes
1,026,684
1,558,475
Accrued warranty
222,702
222,702
Accrued expenses total
$ 2,555,108
$ 2,223,521
NOTE
15 – DEFERRED REVENUE
The
Company’s deferred revenue for the three and six months ended March 31, 2026, and 2025, were as follows:
SCHEDULE OF DEFERRED REVENUE
For the three months ended
For the six months ended
March 31, 2026
March 31, 2025
March 31, 2026
March 31, 2025
Deferred revenue at beginning of period
$ 1,683,471
$ 1,766,705
$ 1,866,014
$ 1,955,635
Net additions:
Deferred software revenues
233,696
445,382
607,796
809,527
Recognized as revenue:
Deferred software revenues
( 526,265 )
( 522,669 )
( 1,082,908 )
( 1,075,744 )
Deferred revenue at end of period
1,390,902
1,689,418
1,390,902
1,689,418
Less: current portion
1,019,351
1,179,536
1,019,351
1,179,536
Long-term deferred revenue at end of period
$ 371,551
$ 509,882
$ 371,551
$ 509,882
For
the three months ended March 31, 2026, and 2025, the Company recognized revenue of $ 495,402
and $ 501,666 ,
respectively. For the six months ended March 31, 2026, and 2025, the Company recognized revenue of $ 914,003 ,
and $ 885,962 ,
respectively, that was previously included in the beginning balance of deferred revenues.
NOTE
16 – CONTRACT ASSETS AND LIABILITIES
Project
contracts typically provide for a schedule of billings on percentage of completion of specific tasks inherent in the fulfillment of the
Company’s performance obligation(s). The schedules for such billings usually do not precisely match the schedule on which costs
are incurred. As a result, contract revenue recognized in the statements of operations can and usually does differ from amounts that
can be billed to the customer at any point during the contract. Amounts by which cumulative contract revenue recognized on a contract
as of a given date exceeds cumulative billings and unbilled receivables to the customer under the contract are reflected as a current
asset in the unaudited condensed consolidated balance sheets under the caption “Contract assets.” Amounts by which cumulative
billings to the customer under a contract as of a given date exceed cumulative contract revenue recognized are reflected as a current
liability in the unaudited condensed consolidated balance sheets under the caption “Contract liabilities.” Conditional retainage
represents the portion of the contract price withheld until the work is substantially complete for assurance of the Company’s obligations
to complete the job.
24
The
following is a summary of the Company’s uncompleted contracts:
SCHEDULE OF CONTRACT ASSETS AND LIABILITIES
March
31, 2025
September
30, 2025
Costs incurred on uncompleted contracts
$ 21,695,817
$ 10,344,923
Estimated gross profit
6,457,872
4,025,531
28,153,689
14,370,454
Applicable billings to
date
( 28,293,504 )
( 15,045,345 )
Net earnings in excess
of billings/(billing in excess of costs)
$ ( 139,815 )
$ ( 674,891 )
For
the three and six months ended March 31, 2026, and 2025, the Company recognized revenue of $ 130,471 and $ 342,725 , and $ 1,402,348 and
$ 1,103,156 , respectively, that was previously included in the beginning balance of contract liabilities.
The
following table summarizes the net activity of the contract assets and contract liabilities for the three and six months ended March
31, 2026, and 2025.
SUMMARY OF CONTRACT ASSETS AND CONTACT LIABILITIES
March
31, 2026
March
31, 2025
March
31, 2026
March
31, 2025
For the three months
ended
For the six months
ended
March
31, 2026
March
31, 2025
March
31, 2026
March
31, 2025
Costs
and Estimated Earnings in Excess of Billings on Uncompleted Contracts
Contract asset,
beginning balance
$ 1,697,691
$ 1,541,241
$ 980,164
$ 985,207
Changes in revenue billed,
contract price or cost estimates
( 151,007 )
( 384,621 )
566,520
171,413
Contract assets acquired
in acquisition
661,885
-
661,885
-
Contract asset, net, ending
balance
$ 2,208,569
$ 1,156,620
$ 2,208,569
$ 1,156,620
Billings
in Excess of Costs and Estimated Earnings on Uncompleted Contracts
Contract liability, beginning
balance
( 1,542,262 )
$ ( 1,279,187 )
( 1,655,055 )
$ ( 1,254,204 )
Changes in revenue billed,
contract price or cost estimates
( 273,585 )
( 645,238 )
( 160,792 )
( 670,221 )
Contract liabilities acquired
in acquisition
( 532,537 )
-
( 532,537 )
-
Contract liability, ending
balance
$ ( 2,348,384 )
$ ( 1,924,425 )
$ ( 2,348,384 )
$ ( 1,924,425 )
Net
Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts
Net billings in excess
of costs, beginning balance
$ 155,429
$ 262,054
$ ( 674,891 )
$ ( 268,997 )
Changes in revenue billed,
contract price or cost estimates
( 424,592 )
( 1,029,859 )
405,728
( 498,808 )
Net billings in excess
of costs acquired in acquisition
129,348
-
129,348
-
Net (earnings in excess
of billings)/costs in excess of billings, ending balance
$ ( 139,815 )
$ ( 767,805 )
$ ( 139,815 )
$ ( 767,805 )
NOTE
17 – RELATED PARTY TRANSACTIONS
On
November 22, 2022, the Company entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity (“SAFE”)
with the Company’s CEO, Saagar Govil, to secure the sale of the subsidiaries Cemtrex Advanced Technologies, Inc, which include
the brand SmartDesk, and Cemtrex XR, Inc., which include the brands Cemtrex XR, Virtual Driver Interactive, Bravo Strong, and good tech
(formerly Cemtrex Labs), to Mr. Govil.
On
January 6, 2025, the Company and Saagar Govil signed an agreement to revise the purchase price structure and payment terms.
The
Agreement’s Purchase Price provisions were amended to reflect that the Purchase Price will solely consist of the royalties based
on the actual revenues generated in the three years following closing. The provision requiring the total sum of royalties to reach a
minimum of $ 820,000 , with any shortfall to be paid by Purchaser, was removed from the Agreement.
Additionally,
it was agreed that the payment terms due under the royalties shall be as follows commencing on January 1, 2025:
● First
Year (January 2025) Monthly Payment: $ 10,000
● Second
Year (January 2026) Monthly Payment: $ 20,000
● Balloon
Payment at the end of the Second Year (December 31, 2026): Total outstanding royalties
This
transaction was approved by the Board of Directors with Saagar Govil abstaining from the vote.
25
Based
on the new payment terms, management determined that it was appropriate to remove the previously recognized royalty receivable of $ 280,545
from the financial statements as of December 31, 2024.
As
of March 31, 2026, there were royalties receivable from the sale of Cemtrex, XR, Inc. of $ 664,000 , all of which is considered short-term
and is presented on the Company’s unaudited Condensed Consolidated Balance Sheet under the caption “Trade receivables, net
– related party. The Company has taken a $ 381,550 allowance for expected credit losses against these royalties.
As
of March 31, 2026, there was $ 548,554 in trade receivables due from the Cemtrex XR successor company, CXR, Inc. Of these receivables
$ 282,450 is the net due on the royalties on CXR Inc.’s revenues. The remaining $ 266,104 is related to the services provided by
Vicon Security Technologies Pvt Ltd. (formerly Cemtrex Technologies Pvt. Ltd.) in the normal course of business. During the year ended
September 30, 2025, the Company recorded $ 60,628 in current expected credit losses on receivables due from CXR Inc.
NOTE
18 – EXPECTED CREDIT LOSSES
The
following table summarized the Company’s activity for expected credit losses for the six months ended March 31, 2026.
SCHEDULE OF CURRENT EXPECTED CREDIT LOSSES
Trade
receivables, net
Contract
assets, net
Royalties
receivable, net - related party
As of September 30, 2025
$ 152,415
$ 9,704
$ 165,771
Expected credit losses, beginning balance
$ 152,415
$ 9,704
$ 165,771
Provision
-
10,395
215,779
Recovery
( 2,409 )
-
-
Write-off
-
-
-
As of March 31, 2026
$ 150,006
$ 20,099
$ 381,550
Expected credit losses, ending balance
$ 150,006
$ 20,099
$ 381,550
NOTE
19 – LEASES
The
Company is party to contracts where we lease property from others under contracts classified as operating leases. The Company primarily
leases office and operating facilities, vehicles, and office equipment. The weighted average remaining term of our operating leases was
approximately 3.23 years at March 31, 2026, and 3.30 years at March 31, 2025. The weighted average discount rate used to measure lease
liabilities was approximately 6.16 % at March 31, 2026, and 6.22 % at March 31, 2025. The Company used the rate implicit in the lease,
where known, or its incremental borrowing rate as the rate used to discount the future lease payments.
The
Company has a single lease that is classified as a finance lease for equipment acquired as part of the Richland acquisition. The remaining
term of this lease is 0.58 years with a discount rate of 1.76 % as of March 31, 2026.
The
Company has elected not to recognize lease assets and liabilities for leases with a term of 12 months or less.
The
Company’s security segment leases approximately 350 square feet of office space in Clovis, CA on a month-to-month lease at a rent
of $ 2,075 per month. Short-term rent expense was $ 12,840 for the six months ended March 31, 2026, and $ 25,671 for the six months ended
March 31, 2025.
26
A
reconciliation of undiscounted cash flows to finance and operating lease liabilities recognized in the unaudited condensed
consolidated balance sheet at March 31, 2026, is set forth below:
SCHEDULE OF RECONCILIATION OF UNDISCOUNTED CASH FLOWS TO OPERATING LEASE LIABILITIES
Years ending
September 30,
Finance Leases
Operating
Leases
Remainder of 2026
$
335,027
$ 728,754
2027
-
1,170,804
2028
-
560,383
2029
-
372,750
2030 and thereafter
-
380,672
Undiscounted lease payments
335,027
3,213,363
Amount representing interest
( 3,209
)
( 322,629 )
Discounted lease payments
331,818
2,890,734
Less short-term lease liabilities
331,818
1,249,135
Long-term lease
liabilities
$
-
$ 1,641,599
Lease
costs for the three and six months ended March 31, 2026, and 2025 are set forth below:
SCHEDULE OF LEASE COSTS
2026
2025
2026
2025
For the three months ended
For the six months ended
March
31,
March
31,
2026
2025
2026
2025
Operating lease costs:
Amortization
of right-of-use assets
313,479
206,795
571,248
461,490
Interest on lease obligations
5,624
1,820
10,860
3,396
Operating lease costs total
319,103
208,615
582,108
464,886
Finance lease costs
Amortization of right-of-use
assets
9,503
-
9,503
-
Interest on lease obligations
496
-
496
-
Finance lease costs total
9,999
-
9,999
-
Short-term lease costs
6,420
11,265
12,840
25,671
Total lease cost
$ 335,522
$ 219,880
$ 604,947
$ 490,557
Other information:
Cash paid for amounts included
in the measurement of lease liabilities:
Operating leases
$ 319,103
$ 208,615
$ 582,108
$ 464,886
Finance lease
$ 6,897
$ -
$ 6,897
$ -
NOTE
20 – LINES OF CREDIT AND LONG-TERM LIABILITIES
Revolving
line of credit
On
October 5, 2023, the Company obtained a revolving line of credit in the amount of $ 5,000,000 from Pathward, N.A.. The interest rate will
be a rate which is equal to three percentage points ( 3 %) in excess of that rate shown in the Wall Street Journal as the prime rate (the
“Effective Rate”) matures twenty-four months 24 from the closing date, and if not specifically terminated, renews for one-year
periods. This loan is secured by the Company’s eligible accounts receivable and eligible finished goods inventory. The Company’s
ability to borrow against the line of credit is limited by the value of the eligible assets. As of March 31, 2026, the Company had enough
eligible assets to access approximately $ 3,100,000 of the credit line. The Company was in compliance with all loan covenants as of March
31, 2026. As of March 31, 2026, and September 30, 2025, this loan had a balance of $ 2,035,697 , and $ 3,176,096 , respectively.
Notes
payable
On
November 7, 2025, the Company issued a note payable to Streeterville Capital, LLC in the amount of $ 7,025,000 .
This note carries interest between November 7, 2025, and December 31, 2025, of SOFR ( 3.87 %
as of December 31, 2025), after December 31, 2025, 8 %,
This Note matures eighteen (18) months from the issuance date with redemptions of up to $ 700,000 a month beginning at six (6) months
from the issuance date. After deduction of legal fees of $ 25,000 ,
the Company received $ 7,000,000
in cash. Additionally, this note contains an additional interest provision that if this note is outstanding on January 1, 2026, a
one-time additional interest fee of $ 1,050,00
which is being amortized over the remaining life of the loan, as of March 31,
2026, there is $ 853,125 of unamortized interest. As of March 31, 2026, this note had a balance of $ 8,281,006 .
27
On
February 5, 2026, the company issued a promissory note to Fulton Bank in the amount of $ 600,000 for the purchase of Richland Industries,
LLC. This note carries interest of 6.09 % requires 60 monthly payments of interest and principal and matures on February 1, 2031 . As of
March 31, 2026, the note had a balance of $ 590,787 .
On
February 5, 2026, the Company acquired a mortgage in the amount of $ 3,920,000
from Fulton Bank to finance the purchase of the property formerly owned by Richland Industries, LLC. The mortgage carries interest
at the Secured Overnight Financing Rate (SOFR) plus 2.75 %
and matures on February
1, 2046 . As of March 31, 2026, this loan had a balance of $ 3,912,200 .
The
following table outlines the Company’s secured liabilities:
SCHEDULE OF LINES OF CREDIT AND AND LONG TERM LIABILITIES
March 31,
September
30,
Interest
Rate
Maturity
2026
2025
Fulton Bank - $312,000 fund equipment
for AIS. This loan is secured by certain assets of the Company.
SOFR plus 2.37%
(6.05% as of March 31, 2026 and 6.61% as of September 30, 2025).
9/30/2029
228,921
257,704
Fulton Bank - $ 312,000 fund equipment
for AIS. This loan is secured by certain assets of the Company.
SOFR plus 2.37 %
( 6.05 % as of March 31, 2026 and 6.61 % as of September 30, 2025).
9/30/2029
228,921
257,704
Fulton Bank mortgage $ 2,476,000 . This loan
is secured by the underlying asset.
SOFR plus 2.62 % ( 6.30 % on
March 31, 2026 and 6.86 % on September 30, 2025).
1/28/2040
1,989,603
2,034,048
Fulton Bank (HEISEY) - $ 1,200,000 mortgage
loan; requires monthly principal and interest payments through August 1, 2043 with a final payment of remaining principal on September
1, 2043 ; The loan is collateralized by 615 Florence Street and 740 Barber Street and guaranteed by AIS and Cemtrex.
SOFR plus 2.80 % per annum
( 6.48 % as of March 31, 2026 and 7.04 % as of September 30, 2025).
9/30/2043
1,129,836
1,146,630
Fulton Bank (HEISEY) - $ 2,160,000 . promissory
note related to purchase of Heisey; requires 84 monthly principal and interest payments ; The note is collateralized by the Heisey
assets and guaranteed by Cemtrex; matures in 2030.
SOFR plus 2.80 % per annum
( 6.48 % as of March 31, 2026 and 7.04 % as of September 30, 2025).
7/1/2030
1,469,944
1,613,677
Fulton Bank (AIS - TN) - $ 3,920,000 mortgage
loan; requires monthly principal and interest payments through January 1, 2046 with a final payment of remaining principal on February
1, 2046 ; The loan is collateralized by 1905 Mines Rd. and guaranteed by AIS and Cemtrex.
SOFR plus 2.75 % per annum
( 6.43 % as of March 31, 2026).
2/1/2046
3,912,200
-
Fulton Bank (AIS - TN) - $ 600,000 . promissory
note related to purchase of AIS - TN; requires 60 monthly principal and interest payments ; The note is collateralized by the AIS
- TN assets and guaranteed by AIS and Cemtrex; matures in 2031.
6.09 %
2/1/2031
590,787
-
Note payable - $ 9,205,000 . Less original issue
discount $ 1,200,000 and legal fees $ 5,000 ,net cash received $ 8,000,000 . 28,572 shares of common stock valued at $ 700,400 recognized
as additional original issue discount. Unamortized original issue discount balance of $ 0 as of September 30, 2025 and September 30,
2024.
8 %
2/22/2027
138,072
7,871,777
Note payable - $ 580,000 . Less original issue
discount $ 75,000 and legal fees $ 5,000 ,net cash received $ 500,000 . Unamortized original issue discount balance of $ 33,333 as of September
30, 2025.
8 %
5/21/2026
647,433
621,773
Note payable - $ 7,025,000 . Less legal fees
$ 25,000 ,net cash received $ 7,000,000 . A $ 1,050,000 additional interest provision was recorded on January 1, 2026
Between November 7, 2025 and
December 31, 2025, SOFR ( 3.87 % as of December 31, 2025), after December 31, 2025, 8 %
5/6/2027
8,281,006
-
Less: Unamortized original issue discount
( 861,458 )
( 33,333 )
Total debt
$ 17,526,344
$ 13,512,276
Less: Current maturities
( 8,770,319 )
( 8,925,497 )
Long-term debt
$ 8,756,025
$ 4,586,779
28
NOTE
21 – STOCKHOLDERS’ EQUITY
Series
1 Preferred Stock
The
Company’s Series 1 Preferred Stock is quoted on the OTC Markets OTCID tier under the symbol “CETXP.”
During
the six months ended March 31, 2026, 135,592 shares of Series 1 Preferred Stock were issued to pay dividends to holders of Series 1 Preferred
Stock.
As
of March 31, 2026, and September 30, 2025, there were 2,840,919 and 2,705,327 shares of Series 1 Preferred Stock issued and 2,776,819
and 2,641,227 shares of Series 1 Preferred Stock outstanding, respectively.
Common
Stock
On
October 2, 2024, November 26, 2024, and September 29, 2025, the Company completed a 60:1 , 35:1 , and 15:1 respectively, reverse stock
split on its common stock. All share and per share data have been retroactively adjusted for the reverse splits.
During
the six months ended March 31, 2026, 29,943 shares of common stock were issued for the exercise 9,981 Series A Warrants, under the Alternative
Cashless Exercise option as adjusted for exercise price adjustments. During the three months ended March 31, 2026, no Series A Warrants
were exercised.
During
the six months ended March 31, 2026, there 67,671 shares of common stock issued for rounding on the September 29, 2025, reverse stock
split. During the three months ended March 31, 2026, no rounding shares were issued.
During
the three and six months ended March 31, 2026, 8,030 , and 2,324,510 shares of common stock were issued for the exercise of 8,030 , and
2,324,510 Series B Warrants, respectively which generated $ 5,675,332 in proceeds.
During
the six months ended March 31, 2026, 3,000,296 shares of the Company’s common stock have been issued to satisfy $ 7,759,168 of notes
payable, $ 84,832 in accrued interest, and $ 11,798,283 of excess value of shares issued recorded as interest expense. Such shares were
issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended. During the three months ended
March 31, 2026, no shares were issued to satisfy debt.
29
Series
A and Series B Warrants
The
following table summarizes information about shares issuable under warrants outstanding as of March 31, 2026.
SCHEDULE SHARES ISSUABLE UNDER WARRANTS OUTSTANDING
Warrant
Shares Outstanding
Weighted
Average Exercise Price
Weighted
Average Remaining Contractual Term (in years)
Outstanding at September 30, 2025
1,667,106
$ 4.84
3.37
Warrants granted
-
Warrants exercised
( 2,354,453 )
$ 2.41
Warrants forfeited
-
Warrants cancelled
-
Exercise price adjustments
2,062,572
Outstanding at March 31, 2026
1,375,225
$ 1.73
2.52
On
October 13, 2025, the Company issued shares of common stock to relieve debt. At the time, the Company had 147,324 Series A Warrants and
1,519,782 Series B Warrants outstanding at an exercise price of $ 5.304 . According to the terms of the Series A and Series B warrants,
in the event of a issuance below the current exercise price, the exercise price resets to the lower of (i) the public offering price,
or (ii) the lowest VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective
date and the number of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On October
17, 2025, it was determined that the exercise price has reset to $ 4.56 .
The
following table illustrates the adjustment.
SCHEDULE OF WARRANTS ADJUSTMENT
Warrants
outstanding
Aggregate
Value
Adjusted
number of warrants outstanding
Series A Warrants
147,324
$ 260,467
57,120
Series B Warrants
1,519,782
$ 8,061,006
1,767,778
On
December 11, 2025, the Company closed on a Securities Purchase agreement of common stock. At the time, the Company had 57,120 Series
A Warrants and 1,757,778 Series B Warrants outstanding at an exercise price of $ 4.56 . According to the terms of the Series A and Series
B warrants, in the event of a public offering, the exercise price resets to the lower of (i) the public offering price, or (ii) the lowest
VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective date and the number
of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On December 17, 2025, it
was determined that the exercise price has reset to $ 2.433 .
The
following table illustrates the adjustment.
Warrants
outstanding
Aggregate
Value
Adjusted
number of warrants outstanding
Series A Warrants
57,120
$ 260,467
107,058
Series B Warrants
1,757,778
$ 8,015,406
3,294,469
On
December 30, 2025, the Company closed on a Securities Purchase agreement of common stock. At the time, the Company had 78,489 Series
A Warrants and 987,987 Series B Warrants outstanding at an exercise price of $ 2.433 . According to the terms of the Series A and Series
B warrants, in the event of a public offering, the exercise price resets to the lower of (i) the public offering price, or (ii) the lowest
VWAP during the period commencing five (5) consecutive trading days commencing on the republic offering effective date and the number
of warrants are adjusted as to keep the aggregate value of the warrants then outstanding remains unchanged. On January 6, 2026, it was
determined that the exercise price has reset to $ 2.25 .
30
The
following table illustrates the adjustment.
Warrants
outstanding
Aggregate
Value
Adjusted
number of warrants outstanding
Series A Warrants
78,489
$ 236,183
104,792
Series B Warrants
987,987
$ 2,403,749
1,068,339
For
the six months ended March 31, 2026, and 2025 the company recognized a loss on the fair value of the common shares issued for the exercised
warrants of $ 4,658,582 and a loss of $ 15,796,105 , respectively, which represents the difference between the fair value of the shares
issued and the value of the warrants exercised.
For
the six months ended March 31, 2026, and 2025 the company recognized a loss on changes in fair value of warrant liability of $ 688,671 ,
and $ 10,020,212 , respectively, which represents the change in the fair value of the of the warrants unexercised at the measurement period.
Equity
Offerings
On
December 11, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant
to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the
Company’s common stock, par value $ 0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $ 3.00 per
share/warrant for aggregate gross proceeds of $ 2,000,000 . The Offering closed on December 11, 2025. The Company issued 310,000 shares
of common stock and prefunded warrants to purchase 356,667 shares of common stock. The Prefunded warrants were immediately exercised,
and the Company issued 666,667 shares of common stock in the aggregate.
On
December 23, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant
to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the
Company’s common stock, par value $ 0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $ 2.50 per share/warrant
for aggregate gross proceeds of $ 2,000,000 . The Offering closed on December 23, 2025. The Company issued 330,000 shares of common stock
and prefunded warrants to purchase 470,000 shares of common stock. The Prefunded warrants were immediately exercised, and the Company
issued 800,000 shares of common stock in the aggregate.
On
December 30, 2025, the Company entered into a Securities Purchase Agreement with a single accredited institutional investor pursuant
to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering securities consisting of shares of the
Company’s common stock, par value $ 0.001 per share, and/or pre-funded warrants to purchase shares of Common Stock at $ 2.25 per
share/warrant for aggregate gross proceeds of $ 2,000,000 . The Offering closed on December 30, 2025. The Company issued 330,000 shares
of common stock and prefunded warrants to purchase 548,889 shares of common stock. The Prefunded warrants were immediately exercised,
and the Company issued 888,889 shares of common stock in the aggregate.
On
January 9, 2026, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”)
with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell
to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s
common stock, par value $ 0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock
(the “Pre-Funded Warrants”), for aggregate gross proceeds of $ 4,000,000 . The Offering closed on January 9, 2026. The Company
issued 400,000 shares of common stock and prefunded warrants to purchase 1,069,507 shares of common stock, all the prefunded warrants
were immediately exercised.
31
NOTE
22 – SHARE-BASED COMPENSATION
For
the six months ended March 31, 2026, and 2025, the Company recognized $ 0 and $ 7,183 of share-based compensation expense on its outstanding
options, respectively. As of March 31, 2026, there was no unrecognized share-based compensation expense.
During
the six months ended March 31, 2026, no options were granted, cancelled, or forfeited.
NOTE
23 – COMMITMENTS AND CONTINGENCIES
From
time to time, the Company and its subsidiaries are involved in legal proceedings that are incidental to the operation of our business.
The Company continues to defend vigorously against all claims. Although the ultimate outcome of any legal matter cannot be predicted
with certainty, based on present information, including assessment of the merits of the particular claim, as well as current accruals
and insurance coverage, the Corporation does not expect that such legal proceedings will have a material adverse impact on its unaudited
condensed consolidated financial statements.
NOTE
24 – INCOME TAXES
For
the three and six months ended March 31, 2026, and 2025, the Company recorded an income tax expense of approximately $ 73,859 and $ 110,525 ,
340,185 , and 231,063 , respectively. These taxes are related to our international operations and state taxes of certain subsidiaries.
As
of year-end 2025, the Company had federal, state, and foreign net operating losses (“NOL”) of approximately $ 68.9 million,
$ 84.0 million, and $ 9.8 million, respectively. The Company has pre 2018 TCJA NOLs and post 2017 TCJA NOLs. Pre 2018 NOLs will expire
in 20 years with the first amount expiring in 2030 and the post 2017 NOLs can be carried forward indefinitely. Generally, state NOLs
have different NOL carryforward rules, with some pre-2018 NOLs being able to be carried forward indefinitely. The first amount of state
NOLs begin to expire in 2026. In accordance with Section 382 of the U.S. Internal Revenue Code, the usage of the Company’s NOL
carryforwards is subject to annual limitations following greater than 50% ownership changes. Tax returns for the years ended 2022 through
2025 are subject to review by tax authorities.
The
Company’s effective tax rates for the three and six months ended March 31, 2026, and 2025, were ( 5.7 %) and 1.27 %, ( 1.79 %) and
( 1.17 %) respectively.
NOTE
25 – SUBSEQUENT EVENTS
On
April 7, 2026, the Company issued 864,588 shares of the Company’s common stock to satisfy $ 580,000 of notes payable,
$ 68,441 in accrued interest, and $ 466,878 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant
to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.
On
April 17, 2026, the Company issued 150,000
shares of the Company’s common stock were issued for the exercise of 150,000
Series B Warrants which generated $ 112,500
in proceeds.
On May 8, 2026, the Company issued 29,157 shares of the Company’s common stock to satisfy $ 25,000 of accrued interest on notes payable, and $ 950 of excess value of shares issued recorded as interest expense. Such shares were issued pursuant to the exemption contained under Section 4(a)(2) of the Securities Act of 1933, as amended.
32
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.